Table 4.
Prognostic Factors for Survival on Multivariate Analysis.
| HR [95 % CI] | p-value | ||
|---|---|---|---|
| Age (Continuous, year): | 1.03 [1.01–1.05] | <0.01 | |
| Tumor Size (Continuous, mm): | 1.01 [0.99–1.02] | 0.23 | |
| Clinical T Stage: | |||
| cT1a | 1(ref) | ||
| cT1b | 1.14 [0.86–1.52] | 0.36 | |
| cT2 - cT4 | 0.94 [0.62–1.42] | 0.77 | |
| Clinical N Stage: | |||
| cN0 | 1(ref) | ||
| cN1 | 1.34 [0.77–2.32] | 0.30 | |
| Clinical M Stage: | |||
| cM0 | 1(ref) | ||
| cM1 | 3.81 [2.33–6.23] | <0.01 | |
| Primary Site: | |||
| Renal Parenchyma | 1(ref) | ||
| Renal Pelvis | 0.54 [0.20–1.47] | 0.23 | |
| Histology: | |||
| Clear Cell Adenocarcinoma | 1(ref) | ||
| Papillary Renal Cell Carcinoma | 0.67 [0.34–1.29] | 0.23 | |
| Transitional | 3.03 [0.83–11.09] | 0.09 | |
| Other/Unspecified | 0.69 [0.35–1.39] | 0.31 | |
| BED3 (Quartiles): | |||
| <145 | 1(ref) | ||
| 145–180 | 0.95 [0.69–1.31] | 0.76 | |
| 180–225 | 1.68 [1.16–2.42] | <0.01 | |
| >225 | 0.69 [0.49–0.95] | <0.01 |